Sundaram Preethi

Chief Strategy OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
1 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)55K$31.50$1.7M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)225K$00
Jul 15, 2026Disposed to issuer(D)68K$00
Jul 15, 2026Disposed to issuer(D)68K$00
Jul 15, 2026Disposed to issuer(D)143K$00
Jul 15, 2026Disposed to issuer(D)138K$00
Jul 15, 2026Disposed to issuer(D)107K$00
Jul 15, 2026Disposed to issuer(D)7K$00
Jul 15, 2026Disposed to issuer(D)11K$00
Jul 15, 2026Disposed to issuer(D)32K$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-26-000182) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.